Metraipolis › archive › dc_3be2bcaae3d1

Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism — Europe PMC PMID:40932870

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40932870
DOI
10.3389/fphar.2025.1641838
License (as archived)
solo-consultazione
Archived
2026-11-10T08:26:45.121Z
SHA-256 of the archived text
fdf4da753cf7b645b20e7996c8783eae7b7570eece797af4f1406177e54d7e38
Stable URL of this page
https://metraipolis.com/documento/dc_3be2bcaae3d1

How to cite

Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism — Europe PMC PMID:40932870 — Europe PMC (en), https://europepmc.org/article/MED/40932870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3be2bcaae3d1 (Metraipolis archive dc_3be2bcaae3d1, sha256 fdf4da753cf7b645b20e7996c8783eae7b7570eece797af4f1406177e54d7e38)
BibTeX
@misc{dc3be2bcaae3d1,
  title = {Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism — Europe PMC PMID:40932870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40932870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3be2bcaae3d1; sha256 fdf4da753cf7b645b20e7996c8783eae7b7570eece797af4f1406177e54d7e38},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40932870. Agents can read the archived copy with the MCP tool read_document.